Lucid Diagnostics Inc. (LUCD)
$0.64-1.54%Close
SELLCRISIS · day 24
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $65M
- Beta
- 1.12
- P/E (TTM)
- -1.29
- Short % float
- 35.43%
- Days to cover
- 10.3
- SI change
- +4.9%
- 1W
- +1.59%
- 1M
- -20.00%
- vs SPY 1W
- +0.43%
- vs SPY 1M
- -22.99%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on LUCD?
- LOPJLB’s latest quantitative signal on Lucid Diagnostics Inc. (LUCD) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is LUCD in?
- Lucid Diagnostics Inc. (LUCD) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Lucid Diagnostics Inc. (LUCD) do?
- Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal conditions or the particularly aggressive esophageal ade…